3-[[4-(3,4-dichlorophenyl)-5-(2-methylpropyl)-1,3-thiazol-2-yl]-(1H-indol-4-ylmethyl)amino]propanoic acid
C25H25Cl2N3O2S — CID 156849350
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[[4-(3,4-dichlorophenyl)-5-(2-methylpropyl)-1,3-thiazol-2-yl]-(1H-indol-4-ylmethyl)amino]propanoic acid
3-[[4-(3,4-dichlorophenyl)-5-(2-methylpropyl)-1,3-thiazol-2-yl]-(1H-indol-4-ylmethyl)amino]propanoic acid (PubChem CID 156849350) has the molecular formula C25H25Cl2N3O2S and a molecular weight of 502.47 g/mol. Its IUPAC name is 3-[[4-(3,4-dichlorophenyl)-5-(2-methylpropyl)-1,3-thiazol-2-yl]-(1H-indol-4-ylmethyl)amino]propanoic acid.
Molecular Properties
| Compound Name | 3-[[4-(3,4-dichlorophenyl)-5-(2-methylpropyl)-1,3-thiazol-2-yl]-(1H-indol-4-ylmethyl)amino]propanoic acid |
|---|---|
| PubChem CID | 156849350 |
| Molecular Formula | C25H25Cl2N3O2S |
| Molecular Weight | 502.47 g/mol |
| Exact Mass | 501.10 |
| IUPAC Name | 3-[[4-(3,4-dichlorophenyl)-5-(2-methylpropyl)-1,3-thiazol-2-yl]-(1H-indol-4-ylmethyl)amino]propanoic acid |
| SMILES | CC(C)Cc1sc(N(CCC(=O)O)Cc2cccc3[nH]ccc23)nc1-c1ccc(Cl)c(Cl)c1 |
| InChI | InChI=1S/C25H25Cl2N3O2S/c1-15(2)12-22-24(16-6-7-19(26)20(27)13-16)29-25(33-22)30(11-9-23(31)32)14-17-4-3-5-21-18(17)8-10-28-21/h3-8,10,13,15,28H,9,11-12,14H2,1-2H3,(H,31,32) |
| InChIKey | YQEWTANVNFHMAR-UHFFFAOYSA-N |
| XLogP | 7.28 |
| TPSA | 69.22 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 502.47 |
| LogP ≤ 5 | 7.28 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156849350 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.